Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.
Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif. Wils P, et al. Among authors: abitbol v. Clin Gastroenterol Hepatol. 2016 Feb;14(2):242-50.e1-2. doi: 10.1016/j.cgh.2015.09.018. Epub 2015 Sep 30. Clin Gastroenterol Hepatol. 2016. PMID: 26432476 Free article.
[Treatment of ulcerative colitis: special situations].
Flourié B, Abitbol V, Lavergne-Slove A, Tennenbaum R, Tiret E. Flourié B, et al. Among authors: abitbol v. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 2):1031-8. doi: 10.1016/s0399-8320(04)95179-2. Gastroenterol Clin Biol. 2004. PMID: 15672573 Free article. Review. French. No abstract available.
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soulé JC, Bourreille A, Metman E, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Abitbol V, Blum-Sperisen S, Mary JY. Marteau P, et al. Among authors: abitbol v. Gut. 2006 Jun;55(6):842-7. doi: 10.1136/gut.2005.076604. Epub 2005 Dec 23. Gut. 2006. PMID: 16377775 Free PMC article. Clinical Trial.
Portomesenteric vein thrombosis in patients with inflammatory bowel disease.
Landman C, Nahon S, Cosnes J, Bouhnik Y, Brixi-Benmansour H, Bouguen G, Colombel JF, Savoye G, Coffin B, Abitbol V, Filippi J, Laharie D, Moreau J, Veyrac M, Allez M, Marteau P; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif. Landman C, et al. Among authors: abitbol v. Inflamm Bowel Dis. 2013 Mar;19(3):582-9. doi: 10.1097/MIB.0b013e31827eea5f. Inflamm Bowel Dis. 2013. PMID: 23385240
Diagnostic delay in a French cohort of Crohn's disease patients.
Nahon S, Lahmek P, Lesgourgues B, Poupardin C, Chaussade S, Peyrin-Biroulet L, Abitbol V. Nahon S, et al. Among authors: abitbol v. J Crohns Colitis. 2014 Sep;8(9):964-9. doi: 10.1016/j.crohns.2014.01.023. Epub 2014 Feb 13. J Crohns Colitis. 2014. PMID: 24529604
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourié B, Cosnes J, Lemann M, Bouhnik Y. Amiot A, et al. Among authors: abitbol v. Am J Gastroenterol. 2014 Sep;109(9):1443-9. doi: 10.1038/ajg.2014.183. Epub 2014 Aug 5. Am J Gastroenterol. 2014. PMID: 25091063
155 results